Sichuan Kelun Pharmaceutical Co., Ltd. (SHE:002422)

China flag China · Delayed Price · Currency is CNY
37.18
-0.41 (-1.09%)
Sep 26, 2025, 2:45 PM CST
-1.09%
Market Cap59.80B
Revenue (ttm)19.07B
Net Income (ttm)2.14B
Shares Out1.59B
EPS (ttm)1.34
PE Ratio27.97
Forward PE17.10
Dividend0.76 (2.03%)
Ex-Dividend DateJun 13, 2025
Volume13,332,355
Average Volume18,718,025
Open37.85
Previous Close37.59
Day's Range36.41 - 37.85
52-Week Range26.44 - 41.72
Beta-0.10
RSI47.82
Earnings DateAug 29, 2025

About SHE:002422

Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China. The company offers infusion products; oral medication and other dosage form; medical devices, such as infusion set, dispensing and injection syringes, detained needles, nebulizer, and vacuum blood collection tubes; over-the-counter products; and APIs for treatment of cardiovascular, IPF, ED, anti-tumor, anti-emetic, antibiotic, VB12, anti-rheumatoid arthritis, multiple sclerosis, anti-schizophrenia, CKD an... [Read more]

Sector Healthcare
Founded 1996
Employees 21,864
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002422
Full Company Profile

Financial Performance

In 2024, SHE:002422's revenue was 21.81 billion, an increase of 1.67% compared to the previous year's 21.45 billion. Earnings were 2.94 billion, an increase of 19.53%.

Financial Statements

News

There is no news available yet.